Vernon Hills, IL, United States of America

Lakshmi Bhagavatula

This inventor holds 6 USPTO granted patents and 15 published patent applications, plus 8 CIPO patents and 1 EPO patent. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Medivir Ab. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakshmi Bhagavatula. Retrieved from https://idiyas.com/inventor/lakshmi-bhagavatula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 15)

% Patents Active = 83.3

CIPO Patents = 8 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 12.4

ph-index = 3

Forward Citations = 80(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

Years Active: 2001-2022

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11512092 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2022-11-29),

2. 11198697 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-12-14),

3. 11186584 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-11-30),

4. 9260411 - Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile (2016-02-16),

5. 6605707 - Process for the preparation of 6-O-propargyl erythromycin derivatives (2003-08-12),

6. 6184376 - Synthesis of acyclic nucleoside derivatives (2001-02-06),

Certainly! Here is an article about the accomplished inventor Lakshmi Bhagavatula.

Title: The Innovative Mind of Lakshmi Bhagavatula: A Trailblazer in Pharmaceutical Innovations

Introduction: Lakshmi Bhagavatula, a talented inventor hailing from Vernon Hills, IL (United States), has made remarkable contributions to the field of pharmaceutical innovations. With a total of 6 patents under her belt, she has revolutionized the industry with her groundbreaking research and discoveries.

Latest Patents: Among her latest patents is the groundbreaking "Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof." This patent focuses on innovative methods for treating rheumatoid arthritis and various spondyloarthritic conditions, showcasing her commitment to improving healthcare globally.

Career Highlights: Lakshmi Bhagavatula has worked with esteemed companies such as AbbVie Inc. and Mediver AB, where she honed her skills and expertise in the pharmaceutical industry. Her dedication to research and development has led to the creation of life-changing pharmaceutical compositions and treatment methods.

Collaborations: Throughout her career, Lakshmi has collaborated with industry experts such as Michael J Rozema and Thomas B Borchardt. These collaborations have been instrumental in advancing her research and bringing her groundbreaking ideas to fruition.

Conclusion: In conclusion, Lakshmi Bhagavatula stands as a beacon of innovation in the pharmaceutical field. Her relentless pursuit of excellence and commitment to improving healthcare have cemented her legacy as a pioneering inventor. With a bright future ahead, she continues to inspire others in the industry to push the boundaries of innovation and make a lasting impact on society.

If you have any more specific requests or need further information, feel free to ask!

Profile summary based on public USPTO records.